Sort
24,576 grants matching “microbiome”
Antimicrobial discovery from metabolomics of nematode pathogen interactions
$620,397Dennis H Kim · Massachusetts Institute Of Technology · R01 · FY2017 · AT
Microbiome acquistion and the progression of inflammation and airway disease in i
$620,391Barbara I Kazmierczak · Yale University · R01 · FY2014 · HL
Cytokines and Inflammatory Bowel Disease
$620,362Fabio Cominelli · Case Western Reserve University · R01 · FY2019 · DK
Gut Microbiota Modulation of Chikungunya Virus Infection and Pathogenesis
$620,348Michael S. Diamond · Washington University · R01 · FY2022 · AI
Lactobacillus probiotic for prevention of recurrent UTI
$620,128Ann E Stapleton · University Of Washington · R01 · FY2011 · DK
A Foundation for the Oral Microbiome and Metagenome
$620,081Floyd E Dewhirst · Ada Forsyth Institute, Inc. · U01 · FY2008 · DE
Research Training in Digestive Diseases
$619,932Raymond T Chung · Massachusetts General Hospital · T32 · FY2021 · DK
The Microbiome, Virome and Host Responses Preceding Ventilator-Associated Pneumon
$619,871Peter M Mourani · University Of Colorado Denver · R01 · FY2015 · HL
Bayesian multivariate 3D spatial modeling for microbiome image analysis
$619,867Jacqueline R Starr · Brigham And Women'S Hospital · R01 · FY2023 · GM
HIV-Associated Lung Disease: The Role of Nasal Mucosal Immunity and Microbiome
$619,771Michael Bradley Drummond · Univ Of North Carolina Chapel Hill · R01 · FY2025 · HL
Biomarkers for Dysbiosis-Related HIV-Associated Cognitive Disorders among Persons Who Inject Drugs in Puerto Rico
$619,730Charles Wood · University Of Nebraska Lincoln · R01 · FY2019 · DA
The relationship of fecal microbiomes and nutritional status in CF
$619,708Lucas R. Hoffman · University Of Washington · R01 · FY2018 · DK
The relationship of fecal microbiomes and nutritional status in CF
$619,708Lucas R. Hoffman · University Of Washington · R01 · FY2017 · DK
Comparative genomic analysis of bacteria species
$619,689Xiaofang Jiang · National Library Of Medicine · ZIA · FY2020 · LM
Repurposing novel selective drugs for treatment and decolonization of vancomycin resistant enterococci
$619,644Mohamed Seleem · Virginia Polytechnic Inst And St Univ · R01 · FY2022 · AI
Interferon hyperactivity, COVID19, and Down syndrome
$619,607Joaquin M. Espinosa · University Of Colorado Denver · R01 · FY2020 · AI
Mucosal Immune Defense Mechanisms of the Urinary Bladder
$619,518Marco Colonna · Washington University · R01 · FY2025 · DK
Metabolic deficits and immune dysfunction in aging people living with HIV
$619,511Daniela Frasca · University Of Miami School Of Medicine · R01 · FY2024 · AG
Azithromycin as adjunctive treatment for uncomplicated severe acute malnutrition: the AMOUR trial
$619,411Catherine Elizabeth Oldenburg · University Of California, San Francisco · R01 · FY2025 · HD
A Phase II randomized controlled trial to evaluate the role of BB-12 in antibiotic-associated diarrhea and its effects on the gut microbiome
$619,407Daniel J Merenstein · Georgetown University · R01 · FY2020 · HD
Project 1: Translational Science of Alopecia Areata
$619,324Angela M Christiano · Columbia University Health Sciences · P50 · FY2020 · AR
Engineering Native E. coli to Detect, Report, and Treat Colorectal Cancer
$619,234Amir Zarrinpar · University Of California, San Diego · U01 · FY2022 · CA
PCB-mediated dysbiosis of the gut microbiome: A missing link in PCB-mediated neurodevelopmental disorders?
$619,202Hans-Joachim Lehmler · University Of Iowa · R01 · FY2024 · ES
PCB-mediated dysbiosis of the gut microbiome: A missing link in PCB-mediated neurodevelopmental disorders?
$619,202Hans-Joachim Lehmler · University Of Iowa · R01 · FY2023 · ES
Dietary Patterns and Risk of Cardiovascular Disease
$619,027Frank B Hu · Harvard School Of Public Health · R01 · FY2018 · HL